AstraZeneca Revenue Down as Key Drugs Lose Patent Protection

U.S. News 

Anglo-Swedish drugmaker AstraZeneca says second-quarter revenue fell amid declining sales of blockbuster drugs Crestor and Seroquel XR, which lost patent protection in the United States last year.